Clinical Trials Logo

Clinical Trial Summary

1. Premenopausal BRCA1 / 2 or PALB2 gene mutation carriers who receive hormone replacement therapy (HRT) after preventive salpingo-oophorectomy (PBSO) have a better quality of sexual, psychological, cardiovascular and bone health than carriers who decline HRT. 2. Premenopausal mutation carriers treated with PBSO who choose HRT have a comparable overall survival and specific survival for breast / gynecological cancer to women who undergo surgery and refuse to receive HRT. 3. Premenopausal mutation carriers treated with PBSO have better overall and specific breast / gynecological cancer survival than non-SOBP carriers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Hereditary Breast and Ovarian Cancer
  • Hereditary Breast and Ovarian Cancer Syndrome

NCT number NCT05409222
Study type Observational
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Teresa Ramon y Cajal, MD PhD
Phone + 34 93 556 56 38
Email tramon@santpau.cat
Status Recruiting
Phase
Start date March 12, 2020
Completion date October 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03246841 - Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. N/A
Completed NCT03421327 - Genetic Risk: Whether, When, and How to Tell Adolescents
Terminated NCT04668521 - Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Completed NCT03075540 - Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer N/A
Enrolling by invitation NCT05721326 - Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition N/A
Recruiting NCT04407611 - Scalable Communication Modalities for Returning Genetic Research Results N/A
Recruiting NCT02302742 - Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Recruiting NCT02516540 - Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers N/A
Completed NCT02324062 - Cancer Genetics Hereditary Cancer Panel Testing N/A
Enrolling by invitation NCT05130606 - CONTIGO - Informing Latinas About HBOC Risk N/A
Completed NCT03511690 - Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment N/A
Completed NCT02087592 - Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers N/A
Active, not recruiting NCT01608074 - Radical Fimbriectomy for Young BRCA Mutation Carriers N/A
Not yet recruiting NCT03979612 - Evaluation of the Adhesion to the GENEPY Network
Terminated NCT04508764 - Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome N/A
Recruiting NCT03050268 - Familial Investigations of Childhood Cancer Predisposition
Completed NCT02786147 - Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
Recruiting NCT03124212 - Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland